| Key Financial Ratios of Celestial Biolabs (in Rs. Cr.) |
Mar 23 |
Mar 22 |
Mar 21 |
Mar 20 |
Mar 19 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
-0.25 |
-0.18 |
-0.08 |
-43.54 |
-0.01 |
|
| Diluted EPS (Rs.) |
-0.25 |
-0.18 |
-0.08 |
-43.54 |
-0.01 |
|
| Cash EPS (Rs.) |
-0.24 |
-0.17 |
-0.06 |
-42.54 |
4.17 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
1.23 |
1.48 |
1.66 |
1.74 |
45.28 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
1.23 |
1.48 |
1.66 |
1.74 |
45.28 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
0.07 |
0.07 |
0.00 |
2.31 |
21.68 |
|
| PBDIT/Share (Rs.) |
-0.24 |
-0.17 |
-0.06 |
-42.53 |
5.36 |
|
| PBIT/Share (Rs.) |
-0.25 |
-0.18 |
-0.08 |
-43.53 |
1.18 |
|
| PBT/Share (Rs.) |
-0.25 |
-0.18 |
-0.08 |
-44.16 |
0.62 |
|
| Net Profit/Share (Rs.) |
-0.25 |
-0.18 |
-0.08 |
-43.54 |
-0.01 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
-320.86 |
-256.67 |
0.00 |
-1,837.25 |
24.69 |
|
| PBIT Margin (%) |
-337.64 |
-277.15 |
0.00 |
-1,880.45 |
5.41 |
|
| PBT Margin (%) |
-339.00 |
-277.62 |
0.00 |
-1,907.79 |
2.86 |
|
| Net Profit Margin (%) |
-339.00 |
-277.62 |
0.00 |
-1,880.91 |
-0.05 |
|
| Return on Networth / Equity (%) |
-20.58 |
-12.22 |
-4.55 |
-2,501.50 |
-0.02 |
|
| Return on Capital Employed (%) |
-4.89 |
-3.45 |
-1.42 |
-811.73 |
2.38 |
|
| Return on Assets (%) |
-3.35 |
-2.38 |
-0.99 |
-570.23 |
-0.02 |
|
| Total Debt/Equity (X) |
4.29 |
3.44 |
3.00 |
2.08 |
0.08 |
|
| Asset Turnover Ratio (%) |
0.01 |
0.01 |
0.00 |
0.08 |
0.42 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.77 |
0.80 |
0.82 |
0.83 |
2.88 |
|
| Quick Ratio (X) |
0.76 |
0.79 |
0.81 |
0.82 |
2.10 |
|
| Inventory Turnover Ratio (X) |
2.57 |
1.77 |
0.00 |
0.00 |
0.10 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
16.46 |
16.10 |
15.82 |
12.74 |
20.75 |
|
| EV/Net Operating Revenue (X) |
97.55 |
109.16 |
0.00 |
2.44 |
0.42 |
|
| EV/EBITDA (X) |
-30.40 |
-42.53 |
-119.78 |
-0.13 |
1.72 |
|
| MarketCap/Net Operating Revenue (X) |
27.04 |
30.93 |
0.00 |
0.87 |
0.27 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
1.64 |
1.36 |
1.21 |
1.16 |
0.13 |
|
| Price/Net Operating Revenue |
27.30 |
31.08 |
0.00 |
0.87 |
0.27 |
|
| Earnings Yield |
-0.13 |
-0.09 |
-0.04 |
-21.55 |
0.00 |
|
Source : Dion Global Solutions Limited
